Comprehensive review of fungal pathogenesis and antifungal therapeutics

100%

Comprehensive review of fungal pathogenesis and antifungal therapeutics

Abstract

Fungal infections, caused by a diverse kingdom of eukaryotic organisms, pose significant challenges to global health due to the increasing incidence of drug-resistant strains. These infections range from superficial to life-threatening systemic diseases, particularly in immunocompromised individuals. The emergence of drug-resistant pathogens like Candida auris has intensified the need for novel antifungal therapies. This comprehensive review explores the pathogenesis of various fungal diseases, the current landscape of antifungal agents, and the mechanisms underlying drug resistance. We discuss the latest advancements in antifungal drug development, including innovative agents in clinical trials, and emphasize the importance of enhancing diagnostic techniques to combat these resilient pathogens. The review aims to provide insights into future directions for effective antifungal strategies, addressing both therapeutic challenges and opportunities in this rapidly evolving field.

One Introduction

Fungi, a kingdom of eukaryotic organisms, have coexisted with humans for a long period of time. Although many fungi are beneficial to industries and ecosystems, others can significantly infect humans. These pathogens can cause a wide range of diseases, ranging from minor skin infections to fatal systemic mycoses. Immerging new fungal infections by the emergence of new or resistant fungal pathogens leads to the growth of the newest antifungal drug. In this article, the distinctive characteristics of fungi as infective agents, the kind of fungal infections, and the current scenario of antifungal treatment are discussed. The increasing incidence of fungal diseases, along with the rise of antifungal resistance, has necessitated an imperative understanding of these pathogens and the development of efficient treatment strategies. An essential component of successful fungal management is the prompt diagnosis and use of suitable antifungal agents. This review will provide the information of existing diagnostic techniques and the classification of antifungal agents based on their targets and mode of action. This review aims to provide a better understanding of this emerging field and guide future clinical practices and investigations by offering an in-depth overview of fungal diseases and its treatment therapy.

One point one Fungi: the pathogen

One point two Fungal infections

One point two point one Emerging fungal infection

One point two point two Invasive fungal infection

Two Common fungal infections

Two point two Aspergillus species

Two point three Mucor species

Three. Several neglected fungal diseases

Four. Antifungal agents

Four point one. History of antifungal agents

Four point two. Current armamentarium of antifungal agents

Four point two point one. Polyenes

Four point two point two. Azoles

Four point two point two point one. First-generation Azoles Clotrimazole, nineteen sixty-nine, Miconazole, nineteen sixty-nine, Econazole, nineteen seventy-four, and Ketoconazole.

Four point two point four Flucytosine

Four point two point five Allylamine

Five Antifungal resistance

Five point one Mechanism of resistance

Six Development of new drug

Six point one Modification and synergistic combination of existing antifungal

Six point one point two Fluconazole

Six point one point three Amphotericin B

Six point one point four Griseofulvin

Six point one point five Some other notable examples

Six point two Fungal vaccines

Seven. Discussion

Eight Conclusion

Overview

The document provides an in-depth analysis of fungal infections and their treatment, emphasizing the challenges posed by drug resistance and the need for novel antifungal therapies. It outlines the pathogenesis of fungal diseases and discusses the latest developments in antifungal drug research.

Key Points

1Fungal infections pose significant health risks, particularly to immunocompromised individuals
2The emergence of drug-resistant strains like Candida auris necessitates new antifungal therapies
3The review discusses advancements in antifungal drug development and diagnostic techniques
4Proper diagnosis and suitable antifungal treatment are critical for managing fungal infections
5The document aims to inform future clinical practices and research in fungal pathogenesis.

Details

Authors: Borsa Rani Neog, Jyotirmoy Das, Biplab Kumar Das, Kalyani Pathak, Manisha Sahariah, Riya Saikia, Jon Jyoti Sahariah
Category: Health and Medicine

PDF
Why art? The role of arts in arts and health
This article addresses the complex relationship between the arts and health, questioning the role of the arts in improving mental and physical well-being. It explores various theoretical constructs and empirical evidence while emphasizing the need for a coherent definition of art to understand its effects on health.
PDF
Oncogenesis
This article examines the role of p52-ZER6 in the metabolic reprogramming of tumor cells, highlighting its impact on the pentose phosphate pathway and tumor progression. The study provides insights into the biochemical processes involved and points to potential therapeutic targets for cancer treatment.
PDF
From library to landscape: integrative annotation workflows for compound libraries in drug repurposing
This article details the creation of two automated annotation workflows designed for the integration of chemical and bioactivity data from various public repositories to support drug repurposing projects.
PDF
Comprehensive Hemodialysis and Nephrology Lecture
This document is a detailed lecture series on hemodialysis and nephrology, discussing the fundamentals of dialysis, historical milestones, advanced modalities, and complications associated with the treatment, aiming to enhance understanding for medical trainees and professionals.
PDF
ShiftScan: A tool for rapid analysis of high-throughput differential scanning fluorimetry data and compound prioritization
This document presents ShiftScan, a standalone tool designed for the rapid analysis of differential scanning fluorimetry (DSF) data in drug discovery, enabling efficient filtering and prioritization of compounds based on thermal transition patterns. It aims to assist researchers in managing large datasets and improving the identification of potential drug candidates.